Noninvasive mapping of endothelial dysfunction in myocardial ischemia by magnetic resonance imaging using an albumin-based contrast agent

K. Vandoorne, M.H. Vandsburger, I. Jacobs, Y. Han, H. Dafni, K Nicolaij, G.J. Strijkers

Research output: Contribution to journalArticleAcademicpeer-review

3 Citations (Scopus)
1 Downloads (Pure)

Abstract

Noninvasive preclinical methods for the characterization of myocardial vascular function are crucial to an understanding of the dynamics of ischemic cardiac disease. Ischemic heart disease is associated with myocardial endothelial dysfunction, resulting in leakage of plasma albumin into the extravascular space. These features can be harnessed in a novel noninvasive three-dimensional magnetic resonance imaging method to measure fractional blood volume (fBV) and vascular permeability (permeability–surface area product, PS) using labeled albumin as a blood pool contrast agent. C57BL/6 mice were imaged before and 3 days after myocardial infarction (MI). Following the quantification of endogenous myocardial R1, the dynamics of intravenously injected albumin-based contrast agent, extravasating from permeable myocardial blood vessels, were tracked on short-axis magnetic resonance images of the entire heart. This study successfully discriminated between infarcted and remote regions at 3 days post-infarct, based on a reduced fBV and increased PS in the infarcted region. These findings were confirmed using ex vivo fluorescence imaging and histology. We have demonstrated a novel method to quantify blood volume and permeability in the infarcted myocardium, providing an imaging biomarker for the assessment of endothelial dysfunction. This method has the potential to three-dimensionally visualize subtle changes in myocardial permeability and to track endothelial function for longitudinal cardiac studies determining pathophysiological processes during infarct healing.

Original languageEnglish
Pages (from-to)1500-1510
Number of pages11
JournalNMR in Biomedicine
Volume29
Issue number11
DOIs
Publication statusPublished - 1 Nov 2016

Fingerprint

Magnetic resonance
Contrast Media
Myocardial Ischemia
Albumins
Blood
Blood Volume
Magnetic Resonance Imaging
Imaging techniques
Blood Vessels
Permeability
Histology
Optical Imaging
Blood vessels
Capillary Permeability
Biomarkers
Inbred C57BL Mouse
Serum Albumin
Longitudinal Studies
Heart Diseases
Myocardium

Keywords

  • albumin
  • magnetic resonance imaging
  • mice
  • myocardial infarction
  • permeability

Cite this

@article{d0e9d7585cc2474c8d3821ad7b4ad4b5,
title = "Noninvasive mapping of endothelial dysfunction in myocardial ischemia by magnetic resonance imaging using an albumin-based contrast agent",
abstract = "Noninvasive preclinical methods for the characterization of myocardial vascular function are crucial to an understanding of the dynamics of ischemic cardiac disease. Ischemic heart disease is associated with myocardial endothelial dysfunction, resulting in leakage of plasma albumin into the extravascular space. These features can be harnessed in a novel noninvasive three-dimensional magnetic resonance imaging method to measure fractional blood volume (fBV) and vascular permeability (permeability–surface area product, PS) using labeled albumin as a blood pool contrast agent. C57BL/6 mice were imaged before and 3 days after myocardial infarction (MI). Following the quantification of endogenous myocardial R1, the dynamics of intravenously injected albumin-based contrast agent, extravasating from permeable myocardial blood vessels, were tracked on short-axis magnetic resonance images of the entire heart. This study successfully discriminated between infarcted and remote regions at 3 days post-infarct, based on a reduced fBV and increased PS in the infarcted region. These findings were confirmed using ex vivo fluorescence imaging and histology. We have demonstrated a novel method to quantify blood volume and permeability in the infarcted myocardium, providing an imaging biomarker for the assessment of endothelial dysfunction. This method has the potential to three-dimensionally visualize subtle changes in myocardial permeability and to track endothelial function for longitudinal cardiac studies determining pathophysiological processes during infarct healing.",
keywords = "albumin, magnetic resonance imaging, mice, myocardial infarction, permeability",
author = "K. Vandoorne and M.H. Vandsburger and I. Jacobs and Y. Han and H. Dafni and K Nicolaij and G.J. Strijkers",
year = "2016",
month = "11",
day = "1",
doi = "10.1002/nbm.3599",
language = "English",
volume = "29",
pages = "1500--1510",
journal = "NMR in Biomedicine",
issn = "0952-3480",
publisher = "Wiley",
number = "11",

}

Noninvasive mapping of endothelial dysfunction in myocardial ischemia by magnetic resonance imaging using an albumin-based contrast agent. / Vandoorne, K.; Vandsburger, M.H.; Jacobs, I.; Han, Y.; Dafni, H.; Nicolaij, K; Strijkers, G.J.

In: NMR in Biomedicine, Vol. 29, No. 11, 01.11.2016, p. 1500-1510.

Research output: Contribution to journalArticleAcademicpeer-review

TY - JOUR

T1 - Noninvasive mapping of endothelial dysfunction in myocardial ischemia by magnetic resonance imaging using an albumin-based contrast agent

AU - Vandoorne, K.

AU - Vandsburger, M.H.

AU - Jacobs, I.

AU - Han, Y.

AU - Dafni, H.

AU - Nicolaij, K

AU - Strijkers, G.J.

PY - 2016/11/1

Y1 - 2016/11/1

N2 - Noninvasive preclinical methods for the characterization of myocardial vascular function are crucial to an understanding of the dynamics of ischemic cardiac disease. Ischemic heart disease is associated with myocardial endothelial dysfunction, resulting in leakage of plasma albumin into the extravascular space. These features can be harnessed in a novel noninvasive three-dimensional magnetic resonance imaging method to measure fractional blood volume (fBV) and vascular permeability (permeability–surface area product, PS) using labeled albumin as a blood pool contrast agent. C57BL/6 mice were imaged before and 3 days after myocardial infarction (MI). Following the quantification of endogenous myocardial R1, the dynamics of intravenously injected albumin-based contrast agent, extravasating from permeable myocardial blood vessels, were tracked on short-axis magnetic resonance images of the entire heart. This study successfully discriminated between infarcted and remote regions at 3 days post-infarct, based on a reduced fBV and increased PS in the infarcted region. These findings were confirmed using ex vivo fluorescence imaging and histology. We have demonstrated a novel method to quantify blood volume and permeability in the infarcted myocardium, providing an imaging biomarker for the assessment of endothelial dysfunction. This method has the potential to three-dimensionally visualize subtle changes in myocardial permeability and to track endothelial function for longitudinal cardiac studies determining pathophysiological processes during infarct healing.

AB - Noninvasive preclinical methods for the characterization of myocardial vascular function are crucial to an understanding of the dynamics of ischemic cardiac disease. Ischemic heart disease is associated with myocardial endothelial dysfunction, resulting in leakage of plasma albumin into the extravascular space. These features can be harnessed in a novel noninvasive three-dimensional magnetic resonance imaging method to measure fractional blood volume (fBV) and vascular permeability (permeability–surface area product, PS) using labeled albumin as a blood pool contrast agent. C57BL/6 mice were imaged before and 3 days after myocardial infarction (MI). Following the quantification of endogenous myocardial R1, the dynamics of intravenously injected albumin-based contrast agent, extravasating from permeable myocardial blood vessels, were tracked on short-axis magnetic resonance images of the entire heart. This study successfully discriminated between infarcted and remote regions at 3 days post-infarct, based on a reduced fBV and increased PS in the infarcted region. These findings were confirmed using ex vivo fluorescence imaging and histology. We have demonstrated a novel method to quantify blood volume and permeability in the infarcted myocardium, providing an imaging biomarker for the assessment of endothelial dysfunction. This method has the potential to three-dimensionally visualize subtle changes in myocardial permeability and to track endothelial function for longitudinal cardiac studies determining pathophysiological processes during infarct healing.

KW - albumin

KW - magnetic resonance imaging

KW - mice

KW - myocardial infarction

KW - permeability

UR - http://www.scopus.com/inward/record.url?scp=84987662422&partnerID=8YFLogxK

U2 - 10.1002/nbm.3599

DO - 10.1002/nbm.3599

M3 - Article

C2 - 27604064

AN - SCOPUS:84987662422

VL - 29

SP - 1500

EP - 1510

JO - NMR in Biomedicine

JF - NMR in Biomedicine

SN - 0952-3480

IS - 11

ER -